Skip to main content

RIGL

Rigel Pharmaceuticals Inc

Company with tickers: RIGL

Market Cap
$684.39M
Shares Outstanding
18,502,080
CIK
1034842
CUSIP
766559702
13F Activity (30d)
4 filings 3 filers
Investor Relations
Investor relations

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Cash spent on buybacks by quarter

Cash deployed each quarter.

Repurchase History

Quarter Ended Cash Spent
2026-03-31 $3,740,000
2025-03-31 $0